Moneycontrol PRO

you are here: HomeNewsBusinessStocksPrefer Aurobindo Pharma: Daljeet Singh Kohli

SHOW NAMES

Trending Topics

Sensex Live Urban Company IPO Kotak Bank Share Price Optivalue Tek Consulting Shares IT Stocks

business

Prefer Aurobindo Pharma: Daljeet Singh Kohli

Daljeet Singh Kohli - Head of Research at IndiaNivesh Securities is of the view that one may prefer Aurobindo Pharma.

first published: Apr 10, 2015 12:36 pm

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347